Clinical Trial: Altropane Dose for Imaging Patients With Suspected Parkinson's Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: Parkinson Disease
Study Type: INTERVENTIONAL
Official Title: An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain Imaging
Brief Summary:
Previous studies showed that a dose of 8 millicuries of Altropane was appropriate for imaging patients with suspected Parkinson's disease.This study will determine if a lower dose (5 millicuries) would suffice.
Read more